Molecular Microbiology Comprehensive Study by Type (Quantitative PCR Detection Diagnostic Kits, Pathogenic Microorganisms Diagnostic Kits), Application (Human, Veterinary) Players and Region - Global Market Outlook to 2030

Molecular Microbiology Market by XX Submarkets | Forecast Years 2024-2030  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Molecular Microbiology
Molecular Microbiology uses various methods to analyze biological markers in the genome and proteome in an individual. Also, it refers to study of micro-organism which involves molecular diagnostic. Its a study of individual genetic code and their cells expression. Advancement in healthcare fueled by growing investment and need for early detection and remedy of diseases have fueled the demand for the very market.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Billion)


Competition among existing players is due to the Industrial lighting market share occupied by leading players. The industry leader is engaged in offering innovative and superior quality products to cater to the ever-growing demand for Industrial lighting Market. The companies are implementing strategic activities such as acquisitions and mergers along with collaboration with companies in other industries to aid them in improving sustenance and maintaining their competitive advantage. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Molecular Microbiology market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Roche (Switzerland), Qiagen (Germany), Illumina (United States), Abbott (United States), Hologic (United States), BioMerieux (France), Danaher (Cepheid) (United States), Myriad Genetics (United States), DAAN Gene (China), Agilent (United States), Genomic Health (United States), BD (United States) and Foundation Medicine (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Thermo Fisher Scientific, Inc [United States], Pacific Biosciences of California, Inc [United States], Oxford Nanopore Technologies, Ltd. [United Kingdom], Eurofins Scientific [Luxembourg], PerkinElmer [United States], Qiagen [Netherlands], 454 Life Sciences [United States] and PierianDx [United States].

Segmentation Overview
AMA Research has segmented the market of Global Molecular Microbiology market by Type (Quantitative PCR Detection Diagnostic Kits and Pathogenic Microorganisms Diagnostic Kits), Application (Human and Veterinary) and Region.



On the basis of geography, the market of Molecular Microbiology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Influencing Trend:
Development of Portable Sequencing Technology Leading to Growth of Molecular Microbiology and Adoption of LIMS (Laboratory Information Management System)

Market Growth Drivers:
Effectiveness in Infectious Diseases and Performing Preventive Cancer Screening and Rising Prevalence of Hospitals Acquired Infections and Others Communicable Infections

Challenges:
Difficulty in Interpretation of Complex Data and Ethical Issues Related in Development of Molecular Microbiology

Restraints:
Lack of Technological Awareness About Molecular Microbiology and Budgetary Constraints in Emerging Countries

Opportunities:
Favorable Government Initiatives in Emerging Countries and Incorporation of Big Data In Healthcare

Market Leaders and their expansionary development strategies
In December 2022, The American Society of Microbiology (ASM) announced the acquisition of the journal Molecular and Cellular Biology by Taylor & Francis (T&F). Clarke & Esposito had the privilege of representing ASM in brokering this notable deal.
In March 2018, ARUP and metagenomics company IDbyDNA, Inc. launched Explify Respiratory which is an NGS test for respiratory infections that helps physicians while diagnosing patients with pneumonia and other respiratory diseases. Using nucleic acid the test identifies over 200 common and rare bacteria and viruses.
The United States Food and Drug Administration finalized two guidelines to accelerate the development of reliable, beneficial Molecular Microbiology based next generation sequencing tests. "The new policies provide a modern and flexible framework to generate data needed to support the FDAs review of NGS-based tests, and give developers new tools to support the efficient development and validation of these technologies" said FDA Commissioner Scott Gottlieb, M.D.

Key Target Audience
Healthcare Industry, NGS Service Providers, Potential Investors, Research Institute, Government Agencies, Market and Research Firms and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Quantitative PCR Detection Diagnostic Kits
  • Pathogenic Microorganisms Diagnostic Kits
By Application
  • Human
  • Veterinary
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Effectiveness in Infectious Diseases and Performing Preventive Cancer Screening
      • 3.2.2. Rising Prevalence of Hospitals Acquired Infections and Others Communicable Infections
    • 3.3. Market Challenges
      • 3.3.1. Difficulty in Interpretation of Complex Data
      • 3.3.2. Ethical Issues Related in Development of Molecular Microbiology
    • 3.4. Market Trends
      • 3.4.1. Development of Portable Sequencing Technology Leading to Growth of Molecular Microbiology
      • 3.4.2. Adoption of LIMS (Laboratory Information Management System)
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Molecular Microbiology, by Type, Application and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Molecular Microbiology (Value)
      • 5.2.1. Global Molecular Microbiology by: Type (Value)
        • 5.2.1.1. Quantitative PCR Detection Diagnostic Kits
        • 5.2.1.2. Pathogenic Microorganisms Diagnostic Kits
      • 5.2.2. Global Molecular Microbiology by: Application (Value)
        • 5.2.2.1. Human
        • 5.2.2.2. Veterinary
      • 5.2.3. Global Molecular Microbiology Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Molecular Microbiology: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Roche (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Qiagen (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Illumina (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Abbott (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Hologic (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. BioMerieux (France)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Danaher (Cepheid) (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Myriad Genetics (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. DAAN Gene (China)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Agilent (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Genomic Health (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. BD (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Foundation Medicine (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
  • 7. Global Molecular Microbiology Sale, by Type, Application and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Molecular Microbiology (Value)
      • 7.2.1. Global Molecular Microbiology by: Type (Value)
        • 7.2.1.1. Quantitative PCR Detection Diagnostic Kits
        • 7.2.1.2. Pathogenic Microorganisms Diagnostic Kits
      • 7.2.2. Global Molecular Microbiology by: Application (Value)
        • 7.2.2.1. Human
        • 7.2.2.2. Veterinary
      • 7.2.3. Global Molecular Microbiology Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Molecular Microbiology: by Type(USD Billion)
  • Table 2. Molecular Microbiology Quantitative PCR Detection Diagnostic Kits , by Region USD Billion (2018-2023)
  • Table 3. Molecular Microbiology Pathogenic Microorganisms Diagnostic Kits , by Region USD Billion (2018-2023)
  • Table 4. Molecular Microbiology: by Application(USD Billion)
  • Table 5. Molecular Microbiology Human , by Region USD Billion (2018-2023)
  • Table 6. Molecular Microbiology Veterinary , by Region USD Billion (2018-2023)
  • Table 7. South America Molecular Microbiology, by Country USD Billion (2018-2023)
  • Table 8. South America Molecular Microbiology, by Type USD Billion (2018-2023)
  • Table 9. South America Molecular Microbiology, by Application USD Billion (2018-2023)
  • Table 10. Brazil Molecular Microbiology, by Type USD Billion (2018-2023)
  • Table 11. Brazil Molecular Microbiology, by Application USD Billion (2018-2023)
  • Table 12. Argentina Molecular Microbiology, by Type USD Billion (2018-2023)
  • Table 13. Argentina Molecular Microbiology, by Application USD Billion (2018-2023)
  • Table 14. Rest of South America Molecular Microbiology, by Type USD Billion (2018-2023)
  • Table 15. Rest of South America Molecular Microbiology, by Application USD Billion (2018-2023)
  • Table 16. Asia Pacific Molecular Microbiology, by Country USD Billion (2018-2023)
  • Table 17. Asia Pacific Molecular Microbiology, by Type USD Billion (2018-2023)
  • Table 18. Asia Pacific Molecular Microbiology, by Application USD Billion (2018-2023)
  • Table 19. China Molecular Microbiology, by Type USD Billion (2018-2023)
  • Table 20. China Molecular Microbiology, by Application USD Billion (2018-2023)
  • Table 21. Japan Molecular Microbiology, by Type USD Billion (2018-2023)
  • Table 22. Japan Molecular Microbiology, by Application USD Billion (2018-2023)
  • Table 23. India Molecular Microbiology, by Type USD Billion (2018-2023)
  • Table 24. India Molecular Microbiology, by Application USD Billion (2018-2023)
  • Table 25. South Korea Molecular Microbiology, by Type USD Billion (2018-2023)
  • Table 26. South Korea Molecular Microbiology, by Application USD Billion (2018-2023)
  • Table 27. Taiwan Molecular Microbiology, by Type USD Billion (2018-2023)
  • Table 28. Taiwan Molecular Microbiology, by Application USD Billion (2018-2023)
  • Table 29. Australia Molecular Microbiology, by Type USD Billion (2018-2023)
  • Table 30. Australia Molecular Microbiology, by Application USD Billion (2018-2023)
  • Table 31. Rest of Asia-Pacific Molecular Microbiology, by Type USD Billion (2018-2023)
  • Table 32. Rest of Asia-Pacific Molecular Microbiology, by Application USD Billion (2018-2023)
  • Table 33. Europe Molecular Microbiology, by Country USD Billion (2018-2023)
  • Table 34. Europe Molecular Microbiology, by Type USD Billion (2018-2023)
  • Table 35. Europe Molecular Microbiology, by Application USD Billion (2018-2023)
  • Table 36. Germany Molecular Microbiology, by Type USD Billion (2018-2023)
  • Table 37. Germany Molecular Microbiology, by Application USD Billion (2018-2023)
  • Table 38. France Molecular Microbiology, by Type USD Billion (2018-2023)
  • Table 39. France Molecular Microbiology, by Application USD Billion (2018-2023)
  • Table 40. Italy Molecular Microbiology, by Type USD Billion (2018-2023)
  • Table 41. Italy Molecular Microbiology, by Application USD Billion (2018-2023)
  • Table 42. United Kingdom Molecular Microbiology, by Type USD Billion (2018-2023)
  • Table 43. United Kingdom Molecular Microbiology, by Application USD Billion (2018-2023)
  • Table 44. Netherlands Molecular Microbiology, by Type USD Billion (2018-2023)
  • Table 45. Netherlands Molecular Microbiology, by Application USD Billion (2018-2023)
  • Table 46. Rest of Europe Molecular Microbiology, by Type USD Billion (2018-2023)
  • Table 47. Rest of Europe Molecular Microbiology, by Application USD Billion (2018-2023)
  • Table 48. MEA Molecular Microbiology, by Country USD Billion (2018-2023)
  • Table 49. MEA Molecular Microbiology, by Type USD Billion (2018-2023)
  • Table 50. MEA Molecular Microbiology, by Application USD Billion (2018-2023)
  • Table 51. Middle East Molecular Microbiology, by Type USD Billion (2018-2023)
  • Table 52. Middle East Molecular Microbiology, by Application USD Billion (2018-2023)
  • Table 53. Africa Molecular Microbiology, by Type USD Billion (2018-2023)
  • Table 54. Africa Molecular Microbiology, by Application USD Billion (2018-2023)
  • Table 55. North America Molecular Microbiology, by Country USD Billion (2018-2023)
  • Table 56. North America Molecular Microbiology, by Type USD Billion (2018-2023)
  • Table 57. North America Molecular Microbiology, by Application USD Billion (2018-2023)
  • Table 58. United States Molecular Microbiology, by Type USD Billion (2018-2023)
  • Table 59. United States Molecular Microbiology, by Application USD Billion (2018-2023)
  • Table 60. Canada Molecular Microbiology, by Type USD Billion (2018-2023)
  • Table 61. Canada Molecular Microbiology, by Application USD Billion (2018-2023)
  • Table 62. Mexico Molecular Microbiology, by Type USD Billion (2018-2023)
  • Table 63. Mexico Molecular Microbiology, by Application USD Billion (2018-2023)
  • Table 64. Company Basic Information, Sales Area and Its Competitors
  • Table 65. Company Basic Information, Sales Area and Its Competitors
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Molecular Microbiology: by Type(USD Billion)
  • Table 78. Molecular Microbiology Quantitative PCR Detection Diagnostic Kits , by Region USD Billion (2025-2030)
  • Table 79. Molecular Microbiology Pathogenic Microorganisms Diagnostic Kits , by Region USD Billion (2025-2030)
  • Table 80. Molecular Microbiology: by Application(USD Billion)
  • Table 81. Molecular Microbiology Human , by Region USD Billion (2025-2030)
  • Table 82. Molecular Microbiology Veterinary , by Region USD Billion (2025-2030)
  • Table 83. South America Molecular Microbiology, by Country USD Billion (2025-2030)
  • Table 84. South America Molecular Microbiology, by Type USD Billion (2025-2030)
  • Table 85. South America Molecular Microbiology, by Application USD Billion (2025-2030)
  • Table 86. Brazil Molecular Microbiology, by Type USD Billion (2025-2030)
  • Table 87. Brazil Molecular Microbiology, by Application USD Billion (2025-2030)
  • Table 88. Argentina Molecular Microbiology, by Type USD Billion (2025-2030)
  • Table 89. Argentina Molecular Microbiology, by Application USD Billion (2025-2030)
  • Table 90. Rest of South America Molecular Microbiology, by Type USD Billion (2025-2030)
  • Table 91. Rest of South America Molecular Microbiology, by Application USD Billion (2025-2030)
  • Table 92. Asia Pacific Molecular Microbiology, by Country USD Billion (2025-2030)
  • Table 93. Asia Pacific Molecular Microbiology, by Type USD Billion (2025-2030)
  • Table 94. Asia Pacific Molecular Microbiology, by Application USD Billion (2025-2030)
  • Table 95. China Molecular Microbiology, by Type USD Billion (2025-2030)
  • Table 96. China Molecular Microbiology, by Application USD Billion (2025-2030)
  • Table 97. Japan Molecular Microbiology, by Type USD Billion (2025-2030)
  • Table 98. Japan Molecular Microbiology, by Application USD Billion (2025-2030)
  • Table 99. India Molecular Microbiology, by Type USD Billion (2025-2030)
  • Table 100. India Molecular Microbiology, by Application USD Billion (2025-2030)
  • Table 101. South Korea Molecular Microbiology, by Type USD Billion (2025-2030)
  • Table 102. South Korea Molecular Microbiology, by Application USD Billion (2025-2030)
  • Table 103. Taiwan Molecular Microbiology, by Type USD Billion (2025-2030)
  • Table 104. Taiwan Molecular Microbiology, by Application USD Billion (2025-2030)
  • Table 105. Australia Molecular Microbiology, by Type USD Billion (2025-2030)
  • Table 106. Australia Molecular Microbiology, by Application USD Billion (2025-2030)
  • Table 107. Rest of Asia-Pacific Molecular Microbiology, by Type USD Billion (2025-2030)
  • Table 108. Rest of Asia-Pacific Molecular Microbiology, by Application USD Billion (2025-2030)
  • Table 109. Europe Molecular Microbiology, by Country USD Billion (2025-2030)
  • Table 110. Europe Molecular Microbiology, by Type USD Billion (2025-2030)
  • Table 111. Europe Molecular Microbiology, by Application USD Billion (2025-2030)
  • Table 112. Germany Molecular Microbiology, by Type USD Billion (2025-2030)
  • Table 113. Germany Molecular Microbiology, by Application USD Billion (2025-2030)
  • Table 114. France Molecular Microbiology, by Type USD Billion (2025-2030)
  • Table 115. France Molecular Microbiology, by Application USD Billion (2025-2030)
  • Table 116. Italy Molecular Microbiology, by Type USD Billion (2025-2030)
  • Table 117. Italy Molecular Microbiology, by Application USD Billion (2025-2030)
  • Table 118. United Kingdom Molecular Microbiology, by Type USD Billion (2025-2030)
  • Table 119. United Kingdom Molecular Microbiology, by Application USD Billion (2025-2030)
  • Table 120. Netherlands Molecular Microbiology, by Type USD Billion (2025-2030)
  • Table 121. Netherlands Molecular Microbiology, by Application USD Billion (2025-2030)
  • Table 122. Rest of Europe Molecular Microbiology, by Type USD Billion (2025-2030)
  • Table 123. Rest of Europe Molecular Microbiology, by Application USD Billion (2025-2030)
  • Table 124. MEA Molecular Microbiology, by Country USD Billion (2025-2030)
  • Table 125. MEA Molecular Microbiology, by Type USD Billion (2025-2030)
  • Table 126. MEA Molecular Microbiology, by Application USD Billion (2025-2030)
  • Table 127. Middle East Molecular Microbiology, by Type USD Billion (2025-2030)
  • Table 128. Middle East Molecular Microbiology, by Application USD Billion (2025-2030)
  • Table 129. Africa Molecular Microbiology, by Type USD Billion (2025-2030)
  • Table 130. Africa Molecular Microbiology, by Application USD Billion (2025-2030)
  • Table 131. North America Molecular Microbiology, by Country USD Billion (2025-2030)
  • Table 132. North America Molecular Microbiology, by Type USD Billion (2025-2030)
  • Table 133. North America Molecular Microbiology, by Application USD Billion (2025-2030)
  • Table 134. United States Molecular Microbiology, by Type USD Billion (2025-2030)
  • Table 135. United States Molecular Microbiology, by Application USD Billion (2025-2030)
  • Table 136. Canada Molecular Microbiology, by Type USD Billion (2025-2030)
  • Table 137. Canada Molecular Microbiology, by Application USD Billion (2025-2030)
  • Table 138. Mexico Molecular Microbiology, by Type USD Billion (2025-2030)
  • Table 139. Mexico Molecular Microbiology, by Application USD Billion (2025-2030)
  • Table 140. Research Programs/Design for This Report
  • Table 141. Key Data Information from Secondary Sources
  • Table 142. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Molecular Microbiology: by Type USD Billion (2018-2023)
  • Figure 5. Global Molecular Microbiology: by Application USD Billion (2018-2023)
  • Figure 6. South America Molecular Microbiology Share (%), by Country
  • Figure 7. Asia Pacific Molecular Microbiology Share (%), by Country
  • Figure 8. Europe Molecular Microbiology Share (%), by Country
  • Figure 9. MEA Molecular Microbiology Share (%), by Country
  • Figure 10. North America Molecular Microbiology Share (%), by Country
  • Figure 11. Global Molecular Microbiology share by Players 2023 (%)
  • Figure 12. Global Molecular Microbiology share by Players (Top 3) 2023(%)
  • Figure 13. Global Molecular Microbiology share by Players (Top 5) 2023(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Roche (Switzerland) Revenue, Net Income and Gross profit
  • Figure 16. Roche (Switzerland) Revenue: by Geography 2023
  • Figure 17. Qiagen (Germany) Revenue, Net Income and Gross profit
  • Figure 18. Qiagen (Germany) Revenue: by Geography 2023
  • Figure 19. Illumina (United States) Revenue, Net Income and Gross profit
  • Figure 20. Illumina (United States) Revenue: by Geography 2023
  • Figure 21. Abbott (United States) Revenue, Net Income and Gross profit
  • Figure 22. Abbott (United States) Revenue: by Geography 2023
  • Figure 23. Hologic (United States) Revenue, Net Income and Gross profit
  • Figure 24. Hologic (United States) Revenue: by Geography 2023
  • Figure 25. BioMerieux (France) Revenue, Net Income and Gross profit
  • Figure 26. BioMerieux (France) Revenue: by Geography 2023
  • Figure 27. Danaher (Cepheid) (United States) Revenue, Net Income and Gross profit
  • Figure 28. Danaher (Cepheid) (United States) Revenue: by Geography 2023
  • Figure 29. Myriad Genetics (United States) Revenue, Net Income and Gross profit
  • Figure 30. Myriad Genetics (United States) Revenue: by Geography 2023
  • Figure 31. DAAN Gene (China) Revenue, Net Income and Gross profit
  • Figure 32. DAAN Gene (China) Revenue: by Geography 2023
  • Figure 33. Agilent (United States) Revenue, Net Income and Gross profit
  • Figure 34. Agilent (United States) Revenue: by Geography 2023
  • Figure 35. Genomic Health (United States) Revenue, Net Income and Gross profit
  • Figure 36. Genomic Health (United States) Revenue: by Geography 2023
  • Figure 37. BD (United States) Revenue, Net Income and Gross profit
  • Figure 38. BD (United States) Revenue: by Geography 2023
  • Figure 39. Foundation Medicine (United States) Revenue, Net Income and Gross profit
  • Figure 40. Foundation Medicine (United States) Revenue: by Geography 2023
  • Figure 41. Global Molecular Microbiology: by Type USD Billion (2025-2030)
  • Figure 42. Global Molecular Microbiology: by Application USD Billion (2025-2030)
  • Figure 43. South America Molecular Microbiology Share (%), by Country
  • Figure 44. Asia Pacific Molecular Microbiology Share (%), by Country
  • Figure 45. Europe Molecular Microbiology Share (%), by Country
  • Figure 46. MEA Molecular Microbiology Share (%), by Country
  • Figure 47. North America Molecular Microbiology Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Roche (Switzerland)
  • Qiagen (Germany)
  • Illumina (United States)
  • Abbott (United States)
  • Hologic (United States)
  • BioMerieux (France)
  • Danaher (Cepheid) (United States)
  • Myriad Genetics (United States)
  • DAAN Gene (China)
  • Agilent (United States)
  • Genomic Health (United States)
  • BD (United States)
  • Foundation Medicine (United States)
Additional players considered in the study are as follows:
Thermo Fisher Scientific, Inc [United States] , Pacific Biosciences of California, Inc [United States] , Oxford Nanopore Technologies, Ltd. [United Kingdom] , Eurofins Scientific [Luxembourg] , PerkinElmer [United States] , Qiagen [Netherlands] , 454 Life Sciences [United States] , PierianDx [United States]
Select User Access Type

Key Highlights of Report


Mar 2024 224 Pages 55 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Roche (Switzerland), Qiagen (Germany), Illumina (United States), Abbott (United States), Hologic (United States), BioMerieux (France), Danaher (Cepheid) (United States), Myriad Genetics (United States), DAAN Gene (China), Agilent (United States), Genomic Health (United States), BD (United States) and Foundation Medicine (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Development of Portable Sequencing Technology Leading to Growth of Molecular Microbiology " is seen as one of major influencing trends for Molecular Microbiology Market during projected period 2023-2030.
The Molecular Microbiology market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Molecular Microbiology Report?